Innovation

Baylor, MD Anderson cancer therapies advance toward commercialization


By Christine Hall | September 5, 2018

Having an idea begin in the laboratory and become a viable treatment or therapy for patients is a goal for researchers across the Texas Medical Center.

Recently, two TMC member institutions saw their cancer therapies gain the distinction of advancing to commercialization.

Ann Leen, Ph.D., and Juan Vera, M.D., along with their colleagues at the Center for Cell and Gene Therapy at Baylor College of Medicine as well as Texas Children’s Hospital and Houston Methodist, developed a therapy for cancer patients that harnesses the patient’s own immune system to fight cancer. The treatment uses a ‘natural’ T cell response that does not require genetic engineering.

In 2015, the group members formed Marker Therapeutics Inc. to facilitate broader patient access to the therapy. Now, Marker is merging with TapImmune Inc., a Florida-based publicly traded company that develops novel immunotherapies for cancer.

The proposed alliance will enable the researchers to perform “advanced-stage clinical testing” to “realize the goal of making immunotherapy a mainstream therapy for patients,” Leen said in a statement.

The partnership also includes a strategic alliance that involves sponsored research, manufacturing support and advancing early-stage clinical trials at Baylor.

Since 2010, more than 25 companies were created within Baylor College of Medicine to advance research from the lab to commercialization, according to Michael Dilling, director of the Baylor Licensing Group, which helps develop commercial relationships that lead to agreements supporting new products and services from Baylor research.

“Entrepreneurial activity has been increasing at Baylor,” he said. “In Marker’s case, that area of development in cell-based therapy is a hot area, and there is commercial interest.”

Meanwhile, The University of Texas MD Anderson Cancer Center has its own history of establishing companies to advance therapies under development within its institution.

“Houston is an untapped gem in the life sciences universe, and this fits with the way Accelerator approaches things,” said David Schubert, chief operating partner at Accelerator Life Science Partners. “There is a lot of great stuff here, which tends to be really early, but driven by powerhouses like MD Anderson, and I am a big believer of what’s going on here.”

This month, MD Anderson and New York-based investment and management firm Accelerator Life Science Partners launched Magnolia Neurosciences Corp.—a company developing a new class of medicines aimed at helping patients suffering from neurodegenerative conditions, such as Alzheimer’s disease and chemotherapy-induced neuropathy in cancer patients.

Magnolia will develop novel therapeutics based on discoveries made by researchers in MD Anderson’s Therapeutics Discovery division, which includes more than 100 clinicians, researchers and drug discovery scientists working to develop innovative treatment options including small molecules, biologics and cell-based therapies.

“This is a really powerful group and we are excited,” said Ferran Prat, Ph.D., vice president of strategic industry ventures at MD Anderson.

Magnolia received $31 million in Series A funding—its first round of venture capital funding.

“Before, it would have been difficult to get investors, but we have established a good track record and have those connections that are on par with the Stanfords and Harvards of the world,” Prat added.

Magnolia also provides David Schubert, chief operating partner at Accelerator, a chance to further his work in Houston. He served as executive director of the Houston Area Translational Research Consortium at Rice University until 2014 and collaborated with Prat since then to understand how the innovation ecosystem works.

“Houston is an untapped gem in the life sciences universe, and this fits with the way Accelerator approaches things,” he said. “There is a lot of great stuff here, which tends to be really early, but driven by powerhouses like MD Anderson, and I am a big believer of what’s going on here.”




Social Posts

profile_image

Veterans Affairs

@DeptVetAffairs

Honoring the Legacy: Soldiers and Veterans run to commemorate 50th anniversary of Hamburger Hill https://t.co/bdrHq2OtnR via @Clarksvillenow

29 mins ago
profile_image

Houston Methodist

@MethodistHosp

@TXMedCenter Thanks for sharing

2 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Injured Veterans Train to Compete in 2019 Warrior Games https://t.co/uXO8FNdB85 via @BN9

2 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

“This research will help protect patients who are most vulnerable to #pneumonia, especially patients with #cancer,” says our @ScottEvansMD.How a new aerosol treatment could help prevent lung diseases: https://t.co/2C8PvkARJR #endcancer

3 hours ago
profile_image

BCMHouston

@bcmhouston

One of our faculty members, Gabriel Lázaro-Muñoz, Ph.D., spoke about his experience with mental illness and how people can take the opportunity to help break the mental health stigma. https://t.co/gxDqFQZo9F #mentalhealth #mentalhealthmonth

3 hours ago
profile_image

UTHealth

@UTHealth

Gabriella Cardone, MD, of @McGovernMed at UTHealth and @memorialhermann provides tips on how to stay safe in the water this summer: https://t.co/UtHAXeFMSO

3 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

We use #clinicaltrials to find better ways to prevent, diagnose and treat #cancer. Search our database to find studies for which you may be eligible: https://t.co/MsDjuQsyqT #ClinicalTrialsDay #endcancer

4 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Today we honor Army Veteran Dimitri del Castillo in remembrance of his service and sacrifice for our country https://t.co/vwDAMmFpBq #VeteranOfTheDay #CarryTheLoad #NoVeteranEverDies

4 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

“I’m alive, so you’ll never hear me complain,” says soft tissue #sarcoma survivor Alex Frankenfeld: https://t.co/Hf08lRVLH8 @CrisRoland @RavinRatan #endcancer

5 hours ago
profile_image

BCMHouston

@bcmhouston

RT @HHSGov: Knowing the signs of mental health distress them makes you better equipped to address them. Here's what to look for, and how to…

5 hours ago
profile_image

Texas Children's

@TexasChildrens

Alyssa Gingrich, social worker who assists liver transplant patients and families at @TexasChildrens, shares why it's important to have an organization like Children's Transplant Initiative as a resource to patient families: https://t.co/LCCyqV0fnS (via @HoustonChron)

6 hours ago
profile_image

Texas Children's

@TexasChildrens

Texas Children's own, Dr. Megan Craddock, share the top mistakes dermatologists say parents make when applying sunscreen to their kids: https://t.co/mQh1Qync5a (via @KPRC2) #texaschildrens

6 hours ago
profile_image

Texas Children's

@TexasChildrens

Texas Children's own, Dr. Megan Craddock, shares the top mistakes dermatologists say parents make when applying sunscreen to their kids: https://t.co/QvzxE8LHiO (via @KPRC2 ) #texaschildrens

6 hours ago
profile_image

University of Houston

@UHouston

RT @UH_Pharmacy: Help assist @UHouston #pharmacy students with scholarships & professional meeting travel costs at UHCOP #Golf Classic Mond…

7 hours ago
profile_image

Rice University

@RiceUniversity

RT @RiceAdmission: It's not only the human variety of owls who live on campus. You just have to look a little harder to find them. https://…

7 hours ago